Nivolumab-Induced Autoimmune Haemolytic Anaemia and Safety of Subsequent Use of Ipilimumab: A Case Report
Autoimmune haemolytic anaemia (AIHA) is a rare immune-related adverse event and appears to be more Understanding the impact of the COVID-19 pandemic on U.S. older adults: self-reported pandemic-related concerns and consequences in a cross-sectional survey study common with anti-PD1/PDL1 than anti-CTLA4.Little is known about the safety of re-treatin